Company Filing History:
Years Active: 1999-2001
Title: Biography of Thomas Anders Millward
Introduction: Thomas Anders Millward is an accomplished inventor based in Basel, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the study of kinases. With a total of three patents to his name, Millward has demonstrated a strong commitment to advancing scientific knowledge and innovation.
Latest Patents: Millward's latest patents include a method of modulating the activity of a polypeptide comprising the activating domain of an Ndr family kinase, which involves influencing the binding of an EF hand-containing calcium binding. Another notable invention describes the identification of a novel widely-expressed human and D. melanogaster serine/threonine protein kinase, designated as nuclear Dbf2-related kinase (Ndr). This invention highlights the use of this kinase for identifying agonists and antagonists, emphasizing its role as a nuclear protein.
Career Highlights: Throughout his career, Millward has been associated with Novartis AG, a leading global healthcare company. His work has focused on the intricate mechanisms of kinases and their implications in various biological processes. His research has contributed to a deeper understanding of cellular signaling pathways.
Collaborations: Millward has collaborated with notable scientists in his field, including Brian Arthur Hemmings. These collaborations have fostered a productive exchange of ideas and have led to advancements in kinase research.
Conclusion: